T he ability to imagine a 3-dimensional (3D) image of the heart was one of the earliest recognized benefits of 2-dimensional (2D) echocardiography at its inception 40 years ago. The ability to build such an image in real time has been a remarkable feat of image processing in the past decade. Intuitively, 3D imaging is the future of echocardiography, and the superiority of this method compared with 2D techniques is most apparent in the assessment of structural abnormalities (e.g., valvular heart disease and septal defects). In addition to these rendered images, quantitation of volumebased measurements, such as ejection fraction (EF), is better performed by 3D than with 2D echocardiographic techniques. After its development in 2D echocardiography, measurement of myocardial strain has recently been implemented in 3D echocardiography by multiple vendors. However, even though the 3D strain technique has been available for some years, many experts have considered that it was not yet ready for clinical implementation.
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In this issue of iJACC, Nagata et al. (1) present the utility of 3D strain to predict adverse events in asymptomatic patients with severe aortic stenosis and preserved EF.
The correct timing of aortic valve replacement (AVR) is debated in this patient group, for whom watchful waiting is widely used. However, the risk of an expectant approach is that the patient could experience rapid deterioration of cardiac function and sudden death (2) .
Although estimating the risks of these events is difficult, statistical modeling has suggested that risk would have to be an order of magnitude higher than currently reported to justify intervention (3). Several attempts have been made to predict an adverse outcome, including assessment of biomarkers and echocardiographic studies. This paper provides us with encouraging information about the value of 3D strain in this setting, but is it enough to change guidelines or practice? Probably not. A weakness of the study is that AVR was included as an adverse event, and therefore, the natural history in these aortic stenosis patients can only be speculated on. Second, the selection process to find suitable studies of adequate quality seemed onerous; 429 patients underwent 3D echocardiography, 133 met inclusion criteria, and 104 entered the study.
Third, the correlation between 2D and 3D global longitudinal strain was only modest (r ¼ 0.56), which seems troubling for 2 ways of measuring the same process. Fourth, and perhaps most important, we read of a 4% to 5% intraobserver variation and a 5% to edvardsen@medisin.uio.no.
